Critical Issues in BDNF Val66Met Genetic Studies of Neuropsychiatric Disorders
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Neurotrophins have been implicated in the pathophysiology of many neuropsychiatric diseases. Brain-derived neurotrophic factor (BDNF) is the most abundant neurotrophin in the brain. Its Val66Met polymorphism (rs6265) is a common and functional single-nucleotide polymorphism (SNP) affecting the activity-dependent release of BDNF. Considering the important role of BDNF in brain function, more than 1,100 genetic studies have investigated this polymorphism. Although these studies have reported some encouraging positive findings initially, most of the findings cannot be replicated in following studies. These inconsistencies in BDNF Val66Met genetic studies may be attributed to many factors such as age, sex, environmental factors, ethnicity, genetic model used for analysis, and gene–gene interaction, which are discussed in this review. We also discuss the results of recent studies that have reported the novel functions of this polymorphism. Because many BDNF polymorphisms and nongenetic factors have been implicated in the complex traits of neuropsychiatric diseases, future studies should apply data mining and machine learning techniques to determine the genetic role of BDNF in neuropsychiatric diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Domingos da Silveira da Luz, A. C., Pereira Dias, G., do Nascimento Bevilaqua, M. C., Cocks, G., Gardino, P. F., Thuret, S., & Nardi, A. E. (2013) · Neuropsychobiology · doi:10.1159/000353269 · Cited by 3,995
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“BDNF Val66Met POLYMORPHISM The first study investigating the function of this polymorphism demonstrated that BDNF Val66Met polymorphism affects activity-dependent BDNF release (Egan et al., 2003).”
BackgroundA molecular and cellular theory of depression
Duman, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190015002 · Cited by 2,129
Mechanisms of stress in the brain
McEwen, B. S., Bowles, N. P., Gray, J. D., Hill, M. N., Hunter, R. G., Karatsoreos, I. N., & Nasca, C. (2015) · Nature Neuroscience · doi:10.1038/nn.4086 · Cited by 1,386
The yin and yang of neurotrophin action
Lu, B., Pang, P. T., & Woo, N. H. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1726 · Cited by 1,356
BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis
Bramham, C. R., & Messaoudi, E. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.003 · Cited by 1,193
Cleavage of proBDNF by tPA/Plasmin Is Essential for Long-Term Hippocampal Plasticity
Pang, P. T., Teng, H. K., Zaitsev, E., Woo, N. T., Sakata, K., Zhen, S., Teng, K. K., Yung, W.-H., Hempstead, B. L., & Lu, B. (2004) · Science · doi:10.1126/science.1100135 · Cited by 1,136
Mice lacking brain-derived neurotrophic factor develop with sensory deficits
Ernfors, P., Lee, K.-F., & Jaenisch, R. (1994) · Nature · doi:10.1038/368147a0 · Cited by 1,067 · cited 1×
“Mutant mice lacking BDNF exhibit developmental brain abnormalities and die soon after birth (Ernfors et al., 1994).”
BackgroundPezawas, L., Verchinski, B. A., Mattay, V. S., Callicott, J. H., Kolachana, B. S., Straub, R. E., Egan, M. F., Meyer-Lindenberg, A., & Weinberger, D. R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2680-04.2004 · Cited by 890
Pruunsild, P., Kazantseva, A., Aid, T., Palm, K., & Timmusk, T. (2007) · Genomics · doi:10.1016/j.ygeno.2007.05.004 · Cited by 699 · cited 1×
“Frontiers in Molecular Neuroscience | www.frontiersin.org 1 May 2018 | Volume 11 | Article 156 The human BDNF gene is located on chromosome 11p13 and has 11 exons and 9 functional promoters that are brain region- and tissue-specific (Pruunsild et al., 2007).”
BackgroundA Genetic Variant BDNF Polymorphism Alters Extinction Learning in Both Mouse and Human
Soliman, F., Glatt, C. E., Bath, K. G., Levita, L., Jones, R. M., Pattwell, S. S., Jing, D., Tottenham, N., Amso, D., Somerville, L. H., et al. (2010) · Science · doi:10.1126/science.1181886 · Cited by 585 · cited 1×
“In addition, the variant mice showed impaired learning of cues that signal safety (Soliman et al., 2010).”
BackgroundVerhagen, M., van der Meij, A., van Deurzen, P. A. M., Janzing, J. G. E., Arias-Vásquez, A., Buitelaar, J. K., & Franke, B. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.109 · Cited by 470 · cited 3×
“…suggested that Val/Met heterozygotes show higher antidepressant therapeutic effects than Val or Met homozygotes, Frontiers in Molecular Neuroscience | www.frontiersin.org 2 May 2018 | Volume 11 | Article 156 particularly Asian patients (Verhagen et al., 2010; Zou et al., 2010; Yan et al., 2014).”
BackgroundGratacòs, M., González, J. R., Mercader, J. M., de Cid, R., Urretavizcaya, M., & Estivill, X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.025 · Cited by 428
Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420
Hosang, G. M., Shiles, C., Tansey, K. E., McGuffin, P., & Uher, R. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-7 · Cited by 292 · cited 2×
“A meta-analysis with a pooled total of 14,233 participants found that the Met allele significantly moderates the link between life stress and depression risk (Hosang et al., 2014).”
BackgroundNotaras, M., Hill, R., & van den Buuse, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.27 · Cited by 274
Population genetic study of the brain-derived neurotrophic factor (BDNF) gene
Petryshen, T. L., Sabeti, P. C., Aldinger, K. A., Fry, B., Fan, J. B., Schaffner, S. F., Waggoner, S. G., Tahl, A. R., & Sklar, P. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.24 · Cited by 267 · cited 5×
“Second, the Met allele is present in different population-specific haplotypes in Caucasians and Asians (Petryshen et al., 2010).”
BackgroundInfluentialVal66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction
Anastasia, A., Deinhardt, K., Chao, M. V., Will, N. E., Irmady, K., Lee, F. S., Hempstead, B. L., & Bracken, C. (2013) · Nature Communications · doi:10.1038/ncomms3490 · Cited by 215
BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity
Bath, K. G., Jing, D. Q., Dincheva, I., Neeb, C. C., Pattwell, S. S., Chao, M. V., Lee, F. S., & Ninan, I. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.318 · Cited by 169 · cited 3×
“BDNFMet/Met mice had decreased basal BDNF protein levels in the hippocampus, which could not be normalized by antidepressant (fluoxetine) administration (Bath et al., 2012b).”
BackgroundMizui, T., Ishikawa, Y., Kumanogoh, H., Lume, M., Matsumoto, T., Hara, T., Yamawaki, S., Takahashi, M., Shiosaka, S., Itami, C., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422336112 · Cited by 141
Harrisberger, F., Smieskova, R., Schmidt, A., Lenz, C., Walter, A., Wittfeld, K., Grabe, H. J., Lang, U. E., Fusar-Poli, P., & Borgwardt, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.04.017 · Cited by 138
BDNF Val66Met and cognition: all, none, or some? A meta‐analysis of the genetic association
Mandelman, S. D., & Grigorenko, E. L. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2011.00738.x · Cited by 122
Zou, Y.-F., Ye, D.-Q., Feng, X.-L., Su, H., Pan, F.-M., & Liao, F.-F. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.005 · Cited by 104
Hajek, T., Kopecek, M., & Höschl, C. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.580005 · Cited by 99 · cited 1×
“Hippocampal volume Hajek et al., 2012 7 399 participants Met carriers had smaller hippocampal volumes than Val homozygotes.”
BackgroundWarnault, V., Darcq, E., Morisot, N., Phamluong, K., Wilbrecht, L., Massa, S. M., Longo, F. M., & Ron, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.06.007 · Cited by 89 · cited 2×
“Using this model, they demonstrated that Met allele increases the risk of compulsive alcohol drinking which can be reversed by directly activating the TrkB receptor (Warnault et al., 2016).”
BackgroundPei, Y., Smith, A. K., Wang, Y., Pan, Y., Yang, J., Chen, Q., Pan, W., Bao, F., Zhao, L., Tie, C., et al. (2012) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32062 · Cited by 67 · cited 1×
“Pei et al., 2012 5 523 cases; 1,220 controls Met increased risk for geriatric depression.”
BackgroundBDNF rs6265 methylation and genotype interact on risk for schizophrenia
Ursini, G., Cavalleri, T., Fazio, L., Angrisano, T., Iacovelli, L., Porcelli, A., Maddalena, G., Punzi, G., Mancini, M., Gelao, B., et al. (2016) · Epigenetics · doi:10.1080/15592294.2015.1117736 · Cited by 62 · cited 1×
“…polymorphism methylation in the peripheral blood of healthy subjects demonstrated that the increased methylation was associated with hypoxia-related early life events and impaired working memory in Val/Val individuals, and the opposite was true for Val/Met individuals (Ursini et al., 2016).”
BackgroundYan, T., Wang, L., Kuang, W., Xu, J., Li, S., Chen, J., & Yang, Y. (2014) · Asia-Pacific Psychiatry · doi:10.1111/appy.12148 · Cited by 46 · cited 2×
“…suggested that Val/Met heterozygotes show higher antidepressant therapeutic effects than Val or Met homozygotes, Frontiers in Molecular Neuroscience | www.frontiersin.org 2 May 2018 | Volume 11 | Article 156 particularly Asian patients (Verhagen et al., 2010; Zou et al., 2010; Yan et al., 2014).”
BackgroundJin, P., Andiappan, A. K., Quek, J. M., Lee, B., Au, B., Sio, Y. Y., Irwanto, A., Schurmann, C., Grabe, H. J., Suri, B. K., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1870 · Cited by 30
Cited by
BDNF as a Promising Therapeutic Agent in Parkinson’s Disease
Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., & Niewiadomska, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031170 · Cited by 504
Numakawa, T., Odaka, H., & Adachi, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113650 · Cited by 353
Stress, hypothalamic–pituitary–adrenal axis, hypothalamic–pituitary–gonadal axis, and aggression.
Mbiydzenyuy, N. E., & Qulu, L.-A. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01393-w · Cited by 255
“(Tsai 2018 ). rodents as well show disrupted signaling in the prefrontal cortex (Bzdok and Dunbar 2020 ).”
BackgroundBrain-derived neurotrophic factor and mental disorders
Lin, C.-C., & Huang, T.-L. (2020) · Biomedical Journal · doi:10.1016/j.bj.2020.01.001 · Cited by 143
“The most widely studied single nucleotide polymorphism (SNP) of BDNF gene is Val66Met polymorphism, also known as rs6265 or G196A polymorphism [3].”
BackgroundCavaleri, D., Moretti, F., Bartoccetti, A., Mauro, S., Crocamo, C., Carrà, G., & Bartoli, F. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105159 · Cited by 146
“It is the most widespread neurotrophin in the central nervous system (CNS) and is largely expressed in crucial regions such as hippocampus, amygdala, hypothalamus, neocortex, and cerebellum (Tsai, 2018; Zhao et al., 2018; Binder and Scharfman, 2004).”
Metadata
- Authors
- Tsai, S.-J.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2018-05-15
- Volume
- 11
- Pages
- 156-156
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2800406500
- Cited by
- 152
- References
- 29
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.